Investment Rating - The report maintains a "Buy" rating for the company, highlighting its potential for growth in the coming years [4]. Core Insights - The company reported a revenue of 10.603 billion RMB for the first three quarters of 2025, representing a year-on-year increase of 23.4%. The net profit attributable to the parent company was 1.185 billion RMB, up 16.6% year-on-year [2]. - The company is expected to achieve an overall revenue growth rate exceeding 30% next year, driven by high capacity utilization and anticipated expansion based on customer demand [3]. - The company is actively developing humanoid robot components, with a focus on three main product categories: harmonic reducers, cycloidal reducers, and rotary joint assemblies [3]. Summary by Sections Performance Review - For Q3 2025, the company reported a revenue of 3.959 billion RMB, a quarter-on-quarter increase of 9.3%, and a net profit of 415 million RMB, up 8.7% quarter-on-quarter [2]. - The gross margin for the first three quarters was 23.16%, with a slight year-on-year decrease of 0.03 percentage points [3]. Operational Analysis - The company maintains a strong net profit margin, with a net profit margin of 10.6% for the first three quarters, despite a year-on-year decrease of 0.8 percentage points [3]. - The company is expected to see significant revenue growth in Q4, with further expansion planned based on customer needs [3]. Financial Forecast and Valuation - The projected net profits for the company from 2025 to 2027 are 1.7 billion RMB, 1.93 billion RMB, and 2.2 billion RMB, respectively [4]. - The report emphasizes the company's leading position in the structural components market and its stable profitability [4].